Article
Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
BioMed research international - 1 Jan 2016
Ho Karen S, Twede Hope, Vanzo Rena, Harward Erin, Hensel Charles H, Martin Megan M, Page Stephanie, Peiffer Andreas, Mowery-Rushton Patricia, Serrano Moises, Wassman E Robert
Abstract excerpt
Copy number variants (CNVs) as detected by chromosomal microarray analysis (CMA) significantly contribute to the etiology of neurodevelopmental disorders, such as developmental delay (DD), intellectual disability (ID), and autism spectrum disorder (ASD). This study summarizes the results of 3.5 years of CMA testing by a CLIA-certified clinical testing laboratory 5487 patients with neurodevelopmental conditions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
